These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12722034

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.
    Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M, Giustini M, Giordano R, Nicolai G, Manni M, Sardella D, Taggi F.
    Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526
    [Abstract] [Full Text] [Related]

  • 3. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
    Ureña P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC.
    J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
    Baskin E, Beşbaş N, Saatçi U, Hasçelik G, Topaloğlu R, Ozen S, Bakkaloğlu A.
    Turk J Pediatr; 2004 Mar; 46(1):28-31. PubMed ID: 15074371
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure.
    Ziółkowska H, Pańczyk-Tomaszewska M, Majkowska Z, Rajkowski T, Debiński A, Przedlacki J, Sawicki A, Ostrowski K, Marciński A, Roszkowska-Blaim M.
    Med Sci Monit; 2001 Mar; 7(5):1034-42. PubMed ID: 11535955
    [Abstract] [Full Text] [Related]

  • 9. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G, Mazzaferro S, Ballanti P, Bonucci E.
    J Endocrinol Invest; 1992 Mar; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract] [Full Text] [Related]

  • 10. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
    Jarava C, Armas JR, Palma A.
    Nefrologia; 2000 Mar; 20(4):362-72. PubMed ID: 11039262
    [Abstract] [Full Text] [Related]

  • 11. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
    Liangos O, Kirchhoff S, Buchholz J, Ketteler M.
    Kidney Blood Press Res; 2018 Mar; 43(4):1222-1230. PubMed ID: 30071519
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S.
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [Abstract] [Full Text] [Related]

  • 13. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
    Fletcher S, Jones RG, Rayner HC, Harnden P, Hordon LD, Aaron JE, Oldroyd B, Brownjohn AM, Turney JH, Smith MA.
    Nephron; 1997 Feb; 75(4):412-9. PubMed ID: 9127327
    [Abstract] [Full Text] [Related]

  • 14. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A, Oprisiu R, Hottelart C, Yverneau PH, Ghazali A, Atik A, Hedri H, Said S, Sechet A, Rasolombololona M, Abighanem O, Sarraj A, El Esper N, Moriniere P, Boudailliez B, Westeel PF, Achard JM, Pruna A.
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [Abstract] [Full Text] [Related]

  • 15. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
    Kobayashi I, Shidara K, Okuno S, Yamada S, Imanishi Y, Mori K, Ishimura E, Shoji S, Yamakawa T, Inaba M.
    Life Sci; 2012 Jan 30; 90(5-6):212-8. PubMed ID: 22154904
    [Abstract] [Full Text] [Related]

  • 16. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
    Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F.
    Nephrol Dial Transplant; 1998 Sep 30; 13(9):2294-302. PubMed ID: 9761512
    [Abstract] [Full Text] [Related]

  • 17. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
    Ziółkowska H, Roszkowska-Blaim M.
    Przegl Lek; 2006 Sep 30; 63 Suppl 3():149-52. PubMed ID: 16898516
    [Abstract] [Full Text] [Related]

  • 18. [Biochemical and histological spectrum of renal osteodystrophy in Argentina].
    Douthat WG, Garay G, de Arteaga J, Fernández Martín JL, Cannata Andía JB, Massari PU.
    Nefrologia; 2003 Sep 30; 23 Suppl 2():47-51. PubMed ID: 12778854
    [Abstract] [Full Text] [Related]

  • 19. [Effect of strontium on bone metabolism in hemodialysis patients].
    Gerstenfeld S, Hinojosa L, Serrano Arias M, Menéndez Rodríguez P, Fernández Martín JL, Marchante JM, García Alonso JI, Sanz-Medel A, Cannata Andía JB.
    Nefrologia; 2003 Sep 30; 23 Suppl 2():52-6. PubMed ID: 12778855
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population.
    Couttenye MM, D'Haese PC, Deng JT, Van Hoof VO, Verpooten GA, De Broe ME.
    Nephrol Dial Transplant; 1997 Oct 30; 12(10):2144-50. PubMed ID: 9351080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.